E-Newsletter - September 2022
Alliance Leadership News


Alliance LEADERSHIP TRANSITION: SUZANNE GEORGE, MD, APPOINTED INTERIM GROUP CHAIR

Suzanne George, MD, a leading medical oncologist and expert in sarcoma management and clinical investigation, has been appointed Interim Group Chair of the Alliance for Clinical Trials in Oncology. An Associate Professor of Medicine at Harvard Medical School and Clinical Director at the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute, Dr. George has served as Alliance Group Vice Chair since 2015 and succeeds Monica M. Bertagnolli, MD. Dr. Bertganolli, who served as Alliance Group Chair from 2011-2022, was recently appointed to serve as President Joe Biden’s pick for Director of the National Cancer Institute.

“I am so proud of the incredible Alliance team,” Dr. Bertagnolli said. “The Group's future is brighter than ever, as there is no lack of talented leadership ready at all levels to smoothly manage a Group Chair transition.”

Dr. George's areas of expertise include soft tissue sarcoma, bone sarcomas, and gastrointestinal stromal tumor (GIST). She has developed and led multiple clinical trials evaluating novel therapeutics for patients with advanced sarcomas and GIST, much of which has impacted the standard of care for patients with these diseases. She has also led one of the largest clinical multidisciplinary sarcoma teams, bringing together medical, surgical, radiation and orthopedic oncologists with the goal of optimizing patient care and outcomes.

In addition to her role as Interim Group Chair, Dr. George will serve as President of the Alliance for Clinical Trials in Oncology Foundation, Alliance NCTN Foundation, Alliance Foundation Trials, LLC, and Alliance Innovation DataLab. Olwen Hahn, MD, Principal Investigator and Director of the Alliance Central Protocol Operations Program, will serve alongside Dr. George as Vice President of the Alliance for Clinical Trials in Oncology Foundation, Alliance NCTN Foundation, Alliance Foundation Trials, LLC, and Alliance Innovation DataLab. Dr. Hahn is also an Associate Professor of Medicine in the Section of Hematology-Oncology at the University of Chicago.

The Alliance Group Chair election, which will be conducted by the Alliance Board of Directors, is proposed for May 2023.

 

 

 

Read more articles in this month's e-newsletter: